336 related articles for article (PubMed ID: 7791086)
41. Selectivity of cytochrome P4502E1 in chlorzoxazone 6-hydroxylation.
Yamazaki H; Guo Z; Guengerich FP
Drug Metab Dispos; 1995 Mar; 23(3):438-40. PubMed ID: 7628313
[No Abstract] [Full Text] [Related]
42. Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes.
Shimada T; Tsumura F; Yamazaki H
Drug Metab Dispos; 1999 Nov; 27(11):1274-80. PubMed ID: 10534312
[TBL] [Abstract][Full Text] [Related]
43. Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1.
Thummel KE; Kharasch ED; Podoll T; Kunze K
Drug Metab Dispos; 1993; 21(2):350-7. PubMed ID: 8097708
[TBL] [Abstract][Full Text] [Related]
44. Metabolism of the alpha,beta-unsaturated ketones, chalcone and trans-4-phenyl-3-buten-2-one, by rat liver microsomes and estrogenic activity of the metabolites.
Kohno Y; Kitamura S; Sanoh S; Sugihara K; Fujimoto N; Ohta S
Drug Metab Dispos; 2005 Aug; 33(8):1115-23. PubMed ID: 15863696
[TBL] [Abstract][Full Text] [Related]
45. Ethosuximide is primarily metabolized by CYP3A when incubated with isolated rat liver microsomes.
Sarver JG; Bachmann KA; Zhu D; Klis WA
Drug Metab Dispos; 1998 Jan; 26(1):78-82. PubMed ID: 9443857
[TBL] [Abstract][Full Text] [Related]
46. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.
Dreisbach AW; Ferencz N; Hopkins NE; Fuentes MG; Rege AB; George WJ; Lertora JJ
Clin Pharmacol Ther; 1995 Nov; 58(5):498-505. PubMed ID: 7586943
[TBL] [Abstract][Full Text] [Related]
47. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
Grubb MF; Diamond S; Christ DD
Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
[TBL] [Abstract][Full Text] [Related]
48. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
Masubuchi Y; Kagimoto N; Narimatsu S; Fujita S; Suzuki T
Drug Metab Dispos; 1993; 21(6):1012-6. PubMed ID: 7905378
[TBL] [Abstract][Full Text] [Related]
49. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
Daniel WA; Syrek M; Ryłko Z; Kot M
Pol J Pharmacol; 2001; 53(6):615-21. PubMed ID: 11985335
[TBL] [Abstract][Full Text] [Related]
50. Chlorzoxazone hydroxylation in microsomes and hepatocytes from cytochrome P450 oxidoreductase-null mice.
Li L; Porter TD
J Biochem Mol Toxicol; 2009; 23(5):357-63. PubMed ID: 19827131
[TBL] [Abstract][Full Text] [Related]
51. Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N'-diacetylbenzidine.
Lakshmi VM; Zenser TV; Davis BB
Drug Metab Dispos; 1997 Apr; 25(4):481-8. PubMed ID: 9107548
[TBL] [Abstract][Full Text] [Related]
52. Pyridine induction of cytochrome P-450 in the rat: role of P-450j (alcohol-inducible form) in pyridine N-oxidation.
Kim SG; Williams DE; Schuetz EG; Guzelian PS; Novak RF
J Pharmacol Exp Ther; 1988 Sep; 246(3):1175-82. PubMed ID: 3418515
[TBL] [Abstract][Full Text] [Related]
53. Epoxidation of acrylonitrile by rat and human cytochromes P450.
Kedderis GL; Batra R; Koop DR
Chem Res Toxicol; 1993; 6(6):866-71. PubMed ID: 8117926
[TBL] [Abstract][Full Text] [Related]
54. Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.
Faucette SR; Hawke RL; Lecluyse EL; Shord SS; Yan B; Laethem RM; Lindley CM
Drug Metab Dispos; 2000 Oct; 28(10):1222-30. PubMed ID: 10997944
[TBL] [Abstract][Full Text] [Related]
55. Metabolism of 2-acetylaminofluorene by two 3-methylcholanthrene-inducible forms of rat liver cytochrome P-450.
Goldstein JA; Weaver R; Sundheimer DW
Cancer Res; 1984 Sep; 44(9):3768-71. PubMed ID: 6744296
[TBL] [Abstract][Full Text] [Related]
56. Monoclonal antibodies to ethanol-induced rat liver cytochrome P-450 that metabolizes aniline and nitrosamines.
Ko IY; Park SS; Song BJ; Patten C; Tan YZ; Hah YC; Yang CS; Gelboin HV
Cancer Res; 1987 Jun; 47(12):3101-9. PubMed ID: 3107803
[TBL] [Abstract][Full Text] [Related]
57. Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17 beta-estradiol by liver microsomes from female rats.
Suchar LA; Chang RL; Thomas PE; Rosen RT; Lech J; Conney AH
Endocrinology; 1996 Feb; 137(2):663-76. PubMed ID: 8593816
[TBL] [Abstract][Full Text] [Related]
58. Noninvolvement of CYP2E1 in the (omega-1)-hydroxylation of fatty acids in rat kidney microsomes.
Amet Y; Zerilli A; Goasduff T; Dréano Y; Berthou F
Biochem Pharmacol; 1997 Oct; 54(8):947-52. PubMed ID: 9354595
[TBL] [Abstract][Full Text] [Related]
59. Tissue, species, and substrate concentration differences in the position-selective hydroxylation of N-nitrosodibutylamine. Relationship to the distribution of cytochrome P-450 isozymes 2 (IIB) and 5 (IVB).
Schulze J; Richter E; Philpot RM
Drug Metab Dispos; 1990; 18(4):398-402. PubMed ID: 1976059
[TBL] [Abstract][Full Text] [Related]
60. Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone.
Gorski JC; Jones DR; Wrighton SA; Hall SD
Xenobiotica; 1997 Mar; 27(3):243-56. PubMed ID: 9141232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
